Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

99
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
99
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

95
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
95
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.3K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.3K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

135
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
135
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

2.2K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.2K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

158
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
158

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis of 3-desoxycollinoketone B and its ability to reduce Alzheimer-associated misfolded proteins.

Nature communications·2026
Same author

Riemannian denoising model for molecular structure optimization with chemical accuracy.

Nature computational science·2026
Same author

Engineering Excited States of Pt-Based Deep-Blue Phosphors to Enhance OLED Stability.

ACS omega·2025
Same author

Transferable Learning of Reaction Pathways from Geometric Priors.

The journal of physical chemistry letters·2025
Same author

MetalloGen: Automated 3D Conformer Generation for Diverse Coordination Complexes.

Journal of chemical information and modeling·2025
Same author

BInD: Bond and Interaction-Generating Diffusion Model for Multi-Objective Structure-Based Drug Design.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025

Related Experiment Video

Updated: Sep 26, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.9K

PIGNet: a physics-informed deep learning model toward generalized drug-target interaction predictions.

Seokhyun Moon1, Wonho Zhung1, Soojung Yang1

  • 1Department of Chemistry, KAIST 291 Daehak-ro, Yuseong-gu Daejeon 34141 Republic of Korea wooyoun@kaist.ac.kr.

Chemical Science
|April 18, 2022
PubMed
Summary

Deep neural network models for drug-target interaction (DTI) prediction struggle with generalization. This study introduces PIGNet, a physics-informed neural network, to enhance DTI model generalization and interpretability for drug discovery.

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

562

Related Experiment Videos

Last Updated: Sep 26, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.9K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

562

Area of Science:

  • Computational chemistry
  • cheminformatics
  • Artificial intelligence in drug discovery

Background:

  • Deep neural network (DNN) models show promise for drug-target interaction (DTI) prediction due to high accuracy and low computational cost.
  • A significant challenge for current DNN-based DTI models is their limited generalization capability in practical drug discovery applications.

Purpose of the Study:

  • To enhance the generalization of deep neural network models for drug-target interaction prediction.
  • To develop a physics-informed deep learning model for more accurate and interpretable binding affinity prediction.

Main Methods:

  • Developed PIGNet, a novel deep neural network model that predicts atom-atom pairwise interactions using physics-informed equations.
  • Parameterized neural networks with physics-informed equations to calculate total binding affinity as the sum of pairwise interactions.
  • Augmented training data with a wider variety of binding poses and ligands to improve model generalization.

Main Results:

  • PIGNet demonstrated superior docking and screening performance compared to existing methods on the CASF 2016 benchmark dataset.
  • The physics-informed approach enabled the interpretation of predicted binding affinities by visualizing the contributions of ligand substructures.
  • The model's ability to provide insights for ligand optimization was highlighted.

Conclusions:

  • PIGNet significantly improves generalization in DTI prediction models through a physics-informed strategy.
  • The model offers interpretable predictions, aiding in the rational design and optimization of drug candidates.
  • This approach advances the field of in silico drug discovery by enhancing both accuracy and interpretability.